TSplus Introduces New Feedback & Roadmap Platform to Enhance the Remote Desktop User Experience
Think Business, Think Hong Kong strengthens Italy-Hong Kong ties and opens new path for Asian collaboration
FUTR Announces Q1 2026 Financial Results
Tenet Reports Third Quarter 2025 Financial Results
Eguana Announces Third Quarter 2025 Financial Results
CALGARY, Alberta and CHICAGO, June 03, 2021 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) and EVERSANA™,…
Sanofi launches €3 million Planet Mobilization fund to support employees’ environmental projects This year, Sanofi…
Nes Ziona, Israel, June 03, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the…
DUBLIN, Ireland, June 03, 2021 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company…
Presentation and conference call will include topline data from all cohorts The risk-benefit profile observed…
Development of novel Camsirubicin analog expands Monopar’s therapeutic pipeline WILMETTE, Ill., June 03, 2021 (GLOBE…
Proceeds will support development of antibody drugs and discovery platform targeting pro-tumorigenic factors produced by…
Introduction of proprietary ETF™ Gene Therapy and first gene candidate, nerve growth factor (NGF), to…
FORT LAUDERDALE, Fla., June 03, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
PITTSBURGH, June 03, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader…
Cambridge, MA, June 03, 2021 (GLOBE NEWSWIRE) — Summit Therapeutics Inc. (NASDAQ: SMMT) invites our…
CRANBURY, N.J., June 03, 2021 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision…
MELBOURNE, Australia, June 03, 2021 (GLOBE NEWSWIRE) — Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or…
Company to Focus its Regenerative Medicine Technology Platform on Developing Orthopedic Product Candidates HST 003…
MALVERN, Pa., June 03, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical…
Clinical trial for MDM2 amplified cancers expected to commence in second half of 2021 NEWARK,…
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY,…
DENVER, June 03, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE:…
Ocugen to have exclusive co-development, manufacturing, and commercialization rights to COVAXIN™ in Canada, in addition…